Interstitial nephritis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:Mohsen Basiri M.D.

Overview

There are no established measures for the secondary prevention of [disease name].

OR

Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].

Secondary Prevention

The most important preventive action is to avoid exposure to the trigger of the acute episode. If the offending medication has clearly been identified, then avoiding future use of the medication is recommended, because AIN may recur on re-exposure to the original antigen. Where known cross-reactivity exists, for example between penicillins and cephalosporins, the risk of using a related agent should be carefully weighed against the benefit of using it. If such an agent is used, the patient should be appropriately monitored for any adverse effects. For the few patients who have chronic inflammatory diseases such as Sjogren syndrome, sarcoidosis, or SLE, adequate control of the underlying condition is important.